baloxavirum marboxilum 40 mg, mannitolum, maltitolum 700 mg, natrii chloridum corresp. natrium 23.59 mg, hypromellosum, povidonum K 25, silica colloidalis anhydrica, sucralosum, talcum, aromatica (Erdbeer) ad granulatum pro 2 g.
Packungsbestandteile
Granulat zur Herstellung einer Suspension zum Einnehmen
Active Agent
Dose
Baloxavirum Marboxilum
40 mg
Inactive agents
Dose
Aromatica (Erdbeer) ad Granulatum
2 g
Hypromellosum
Maltitol
700 mg
Mannitol
Sodium Chloride
Povidonum K
25
Silica Colloidalis Anhydrica
Sucralosum
Talcum
Source
Data was imported : 04.11.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
